{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06497569",
            "orgStudyIdInfo": {
                "id": "MCC-23230"
            },
            "organization": {
                "fullName": "H. Lee Moffitt Cancer Center and Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer",
            "officialTitle": "Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer (STRONG-GEC)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "support-through-remote-observation-and-nutrition-guidance-program-for-individuals-with-gastroesophageal-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-05",
            "studyFirstSubmitQcDate": "2024-07-05",
            "studyFirstPostDateStruct": {
                "date": "2024-07-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "H. Lee Moffitt Cancer Center and Research Institute",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "United States Department of Defense",
                    "class": "FED"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients."
        },
        "conditionsModule": {
            "conditions": [
                "GastroEsophageal Cancer"
            ],
            "keywords": [
                "Nutrition Support"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "To reduce risk of bias, only assessors unaware of randomization status will be used to assess study outcomes.",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "STRONG Intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive an initial consultation and biweekly follow-up visits with a study dietitian for 90 days.\n\nDuring the follow-up visits, the study dietitian will review the dietary plan and goals, review the dietary food log, and discuss any challenges with dietary intake and recommendations for improving dietary intake.\n\nParticipants will keep a daily diary of food intake with a Fitbit smartphone app and a Fitbit wearable device for 90 days, complete 6 questionnaires, and have the option to participate in a voluntary interview about the intervention.",
                    "interventionNames": [
                        "Behavioral: Dietitian Consultation",
                        "Behavioral: Survey",
                        "Behavioral: Fitbit Data Collection",
                        "Behavioral: Social Determinants of Health Survey (SDOH)"
                    ]
                },
                {
                    "label": "Usual Care Intervention",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will be referred to a study dietitian based on their standard-care clinician's discretion, complete 6 questionnaires, and have the option to participate in a voluntary interview about the intervention.",
                    "interventionNames": [
                        "Behavioral: Dietitian Consultation",
                        "Behavioral: Survey",
                        "Behavioral: Referral to Dietitian"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Dietitian Consultation",
                    "description": "Participants will meet with a dietitian who will provide individualized nutrition counseling and dietary goals for calorie and protein intake.\n\nBi-weekly, 30-minute dietitian telehealth visits will be conducted via ZOOM videoconferencing at the pre-intervention baseline visit, monthly during the intervention period (up to 90 days) and at the 4 and 6 month timepoints post-intervention.",
                    "armGroupLabels": [
                        "STRONG Intervention",
                        "Usual Care Intervention"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Survey",
                    "description": "Surveys will be conducted using the PG-SGA short form19-21 and a brief symptom assessment tool that captures additional nutrition-impact symptoms not captured by the PG-SGA (e.g., swallowing difficulty) measured by the FACT Esophageal and Gastric Cancer scales and the FAACT anorexia/cachexia scales 22,23 through REDCap.\n\nSurveys are completed at the pre-intervention baseline visit and monthly during the intervention period prior to the dietitian visits (up to 90 days), and at the 4 and 6 month timepoints post-intervention.",
                    "armGroupLabels": [
                        "STRONG Intervention",
                        "Usual Care Intervention"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Fitbit Data Collection",
                    "description": "Participants will log food intake while sharing their data with a dietitian during the 30-minute dietitian telehealth visits at the pre-intervention baseline visit, monthly during the intervention period (up to 90 days) and at the 4 and 6 month timepoints post-intervention.",
                    "armGroupLabels": [
                        "STRONG Intervention"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Referral to Dietitian",
                    "description": "Usual Care condition referral to a dietitian based on physician discretion.",
                    "armGroupLabels": [
                        "Usual Care Intervention"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Social Determinants of Health Survey (SDOH)",
                    "description": "Participants will complete a SDOH Survey that captures individual-level factors (insurance type, preferred language, educational attainment, annual household income, digital health literacy, financial toxicity, and self-reported barriers to care \\[e.g., transportation\\]) and structural-level factors (neighborhood disadvantage, rural residence).\n\nDigital health literacy will be measured using the validated eHEALS scale, an 8-item measure assessing confidence with finding, evaluating, and applying electronic information to inform health decision-making (score \u2264 30 indicates low literacy).",
                    "armGroupLabels": [
                        "STRONG Intervention"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Recruitment Rate- Feasibility",
                    "description": "The Study will be deemed feasible \u2265 50% of eligible patients are enrolled.",
                    "timeFrame": "Up to 48 Months"
                },
                {
                    "measure": "Retention Rate- Feasibility",
                    "description": "The Study will be deemed feasible if \u2265 70% of participants enrolled at baseline are retained at the end of the intervention period.",
                    "timeFrame": "Up to 90 Days"
                },
                {
                    "measure": "Patient-reported outcome completion-Feasibility",
                    "description": "The Study will be deemed feasible if \u2265 70% of participants enrolled submit 4 of the 6 study assessments.",
                    "timeFrame": "Up to 6 Months"
                },
                {
                    "measure": "Food Log Data Collection-Feasibility",
                    "description": "The study will be deemed feasible if \u2265 70% of participants enrolled log food for greater than 80% of study days (72 out of 90).",
                    "timeFrame": "Up to 6 Months"
                },
                {
                    "measure": "Adherence to Dietitian Visits- Feasibility",
                    "description": "The Study will be deemed feasible if \u2265 70% of participants enrolled attend 4 out of 6 dietitian visits.",
                    "timeFrame": "Up to 6 Months"
                },
                {
                    "measure": "Fidelity to Study Protocol- Feasibility",
                    "description": "The Study will be deemed feasible if 20% of randomly audited dietitian visits have documented PG-SGA and calorie and protein goals",
                    "timeFrame": "Up to 6 Months"
                },
                {
                    "measure": "Patient Rating of MyPlate app-Feasibility",
                    "description": "The Study will be deemed feasible if \u2265 70% of participants rate the MyPlate app as east-to use utilizing a validated usability scale (score \u2265 60).",
                    "timeFrame": "Up to 6 Months"
                },
                {
                    "measure": "Participant Satisfaction- Acceptability",
                    "description": "Patient satisfaction with the intervention will be deemed acceptable if \u2265 70% of participants rate the intervention as satisfactory utilizing a validated 4 item scale (score range 0-20).\n\nA cutoff score of \u2265 12 based on prior studies to define intervention acceptability will be used.",
                    "timeFrame": "Up to 6 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Malnutrition -Nutritional Status",
                    "description": "Nutritional status will be measured using the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form (score range: 0-35) and categorized based on a prior validation study (0-1 well nourished, 2-8 at-risk, \u2265 9 severely malnourished).",
                    "timeFrame": "Baseline, 3 Months, 6 Months"
                },
                {
                    "measure": "Malnutrition-Significant weight loss",
                    "description": "Significant weight loss is defined as \\>5% and \\>10% of body weight. This will be calculated based on weight obtained during clinic visits.",
                    "timeFrame": "Baseline, 3 Months, 6 Months"
                },
                {
                    "measure": "Malnutrition - Low BMI",
                    "description": "Low BMI will be defined as \\<20kg/m\u00b2 for individuals \\<70 years old and \\<22kg/m2 for individuals \u226570 years old.\n\nThis will be calculated based on weight and height measurements from clinic visits.",
                    "timeFrame": "Baseline, 3 Months, 6 Months"
                },
                {
                    "measure": "Malnutrition - Low Skeletal Muscle Mass",
                    "description": "Low muscle mass will be estimated by calculating skeletal muscle index (SMI) from routinely collected CT scans at baseline, 3 months and 6 months (CT scans are conducted every 3 months). Low muscle mass will be defined as SMI \u226438.5 cm2 /m2 for females and SMI \u226452.4 cm2 /m2 for males.",
                    "timeFrame": "Baseline, 3 Months, 6 Months"
                },
                {
                    "measure": "Quality of Life Questionnaires",
                    "description": "Quality of Life will be measured using the Functional Assessment of Cancer Therapy - General (FACT-G) Scale and the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) subscales.\n\n(FACT-G) and (FAACT) Questionnaires include questions about the participant's physical, social, emotional and functional well-being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher score indicates a better quality of life.",
                    "timeFrame": "Baseline, 3 Months, 6 Months"
                },
                {
                    "measure": "Treatment Adherence",
                    "description": "Treatment Adherence will be measured by obtaining scheduling and electronic health record (EHR) data to estimate adherence to chemotherapy and/or radiation therapy.\n\nComparison of will be made of planned vs. received chemotherapy and/or radiation regimens to define 1) treatment delay (yes/no); 2) dose reduction (yes/no); and 3) treatment discontinuation (yes/no). We will also document receipt of surgery (yes/no).",
                    "timeFrame": "Baseline, 3 Months, 6 Months"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "description": "Progression Free Survival (PFS) status will be obtained from the cancer center registry to estimate overall survival (the time from random assignment to death from any cause) and progression-free survival (the time from random assignment to disease progression or death from any cause).",
                    "timeFrame": "Up to 48 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must be 18 years of age or older\n* Participants must have locally advanced or metastatic gastroesophageal cancer (GEC)\n* Participants must plan to initiate chemotherapy and/or radiation therapy with a plan to have surgery or definitive treatment follow up at Moffitt\n* Participants must be able to speak and read Spanish and/or English\n* Participants must be able to provide informed consent\n\nExclusion Criteria:\n\n* Participants have a documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g. severe dementia)\n* Use of feeding tubes at the time of study enrollment",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Emma Hume",
                    "role": "CONTACT",
                    "phone": "813-745-6426",
                    "email": "Emma.Hume@moffitt.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kea Turner, PhD, MA",
                    "affiliation": "Moffitt Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Jose Pimiento, MD",
                    "affiliation": "Moffitt Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emma Hume",
                            "role": "CONTACT",
                            "phone": "813-745-6426",
                            "email": "Emma.Hume@moffitt.org"
                        },
                        {
                            "name": "Kea Turner, PhD, MPH, MA",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Jose Pimiento, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Moffitt Cancer Center Clinical Trials website",
                    "url": "http://www.moffitt.org/clinical-trials-research/clinical-trials/"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}